WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsScworx Corp (WORX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 103545% more annual revenue ($2.89B vs $2.78M). MMED leads profitability with a -7.3% profit margin vs -139.7%. MMED earns a higher WallStSmart Score of 37/100 (F).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

WORX

Avoid

31

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 5.0Quality: 5.5
Piotroski: 4/9Altman Z: -5.70

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED0 strengths · Avg: 0/10

No standout strengths identified

WORX2 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Areas to Watch

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

WORX4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$2.01M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-74.2%2/10

ROE of -74.2% — below average capital efficiency

Revenue GrowthGrowth
-7.1%2/10

Revenue declined 7.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : WORX

The strongest argument for WORX centers on Price/Book, Debt/Equity.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Bear Case : WORX

The primary concerns for WORX are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

MMED is growing revenue faster at 13.1% — sustainability is the question.

WORX generates stronger free cash flow (-358,080), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MMED scores higher overall (37/100 vs 31/100) and 13.1% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Scworx Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Scworx Corp (WORX) is a leading provider of advanced healthcare data solutions, focused on streamlining clinical data and insights for healthcare providers and stakeholders. Leveraging innovative technology, Scworx enhances operational efficiency and elevates care quality, enabling institutions to make data-driven decisions through comprehensive analytics. The company's strategic emphasis on scalability and innovation positions it well to address the increasing demand for data-centric solutions in the healthcare sector, ultimately driving improved patient outcomes and fostering effective cost management strategies. Scworx's commitment to transforming healthcare delivery underscores its pivotal role in a rapidly evolving market landscape.

Visit Website →

Want to dig deeper into these stocks?